Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alkem Laboratories Limited M&A Activity 2021

Apr 6, 2021

61611_rns_2021-04-06_17d74352-49e5-45e0-b286-f2fa83d2c91c.pdf

M&A Activity

Open in viewer

Opens in your device viewer

==> picture [596 x 136] intentionally omitted <==

Date: 06[th] April, 2021

To To National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Plot No. C-1, Market Operations Department, Block G, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra East, Mumbai – 400051 Dalal Street, Mumbai – 400001 Scrip Code – 539523 Scrip Symbol – ALKEM

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sirs,

We refer to our disclosure, dated 01[st] April, 2021, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 informing interalia that DigiHealth Technologies LLP, (the wholly owned entity of our investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP)), has agreed to acquire 100% ownership interest in Pharmarack Technologies Private Limited (‘Pharmarack’) in tranches.

Further to the above, we wish to inform you that the above-referred entity, DigiHealth Technologies LLP has completed on 05[th] April, 2021 the acquisition of 91.8% of shareholding in Pharmarack by purchase of shares from multiple shareholders in various lots.

This is for your information and dissemination.

Yours faithfully,

For Alkem Laboratories Limited

Manish Digitally signed by Manish Narang Date: 2021.04.06 Narang 20:01:13 +05'30' __________________________

Manish Narang President – Legal, Company Secretary & Compliance Officer